Commit To Purchase Crinetics Pharmaceuticals At $15, Earn 16.9% Annualized Using Options
Investors eyeing a purchase of Crinetics Pharmaceuticals Inc (Symbol: CRNX) stock, but tentative about paying the going market price of $20.31/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in
:max_bytes(150000):strip_icc():format(jpeg)/PaperworkatDesk-1a3837aec527439dbbf86d99a89611ba.jpg "2024 and 2025 Federal Income Tax Brackets, Standard Deductions, and Tax Rates")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1245836826-2b88234057c442f7bf5538ddb7f7584a.jpg "What It Would Take for the U.S. Dollar To Collapse")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1336655800-0cde652f461b4771aa45601032b5420b.jpg "Home Equity Loans and Divorce")
:max_bytes(150000):strip_icc():format(jpeg)/WhatIstheThree-YearRuleAug.262021-09d1295e78a743ecac4a31c6c042d52d.jpg "Reverse Mortgage Income Requirements")